ClinConnect ClinConnect Logo
Search / Trial NCT06641804

Vaginal Prolapse Pessary Material Trial PVC vs Silicon

Launched by PRINCESS MARGARET HOSPITAL, HONG KONG · Oct 10, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Pelvic Organ Prolpase Ring Pessary Silicon Ring Pessary Pvc Ring Pessary

ClinConnect Summary

This clinical trial is looking at two types of vaginal ring pessaries, which are devices used to help manage pelvic organ prolapse (POP). The goal is to see how these different materials—PVC (polyvinyl chloride) and silicone—affect complications, patient satisfaction, and any pain experienced during the process of changing the pessary. Over a period of six months, participants will share their experiences and answer questions about their symptoms related to prolapse.

To participate, women aged 18 and older who can read traditional Chinese and have been diagnosed with a specific stage of pelvic organ prolapse are eligible. They should currently be using a PVC pessary as a long-term solution for their condition. Participants will be randomly assigned to use either a PVC or silicone pessary and will need to attend follow-up appointments over the next six months to track their health and experiences with the device. This trial is currently not recruiting participants, but it aims to provide valuable information on which material may work better for women managing POP.

Gender

FEMALE

Eligibility criteria

  • Inclusion criteria
  • At least 18 years old who understand written traditional Chinese
  • Diagnosed with stage 1-4 POP according to the standard of Pelvic organ prolapse Quantification (POP-Q)
  • Using PVC pessary as long term management for POP
  • Willing to participate and provide a written informed consent.
  • Exclusion criteria
  • Do not understand or comprehend written traditional Chinese
  • Cannot provide written consent
  • Vaginal complication requiring discontinuation of pessary use
  • Unable to follow up clinic 6 months later
  • Pregnant or lactating
  • Recruited in other research studies

About Princess Margaret Hospital, Hong Kong

Princess Margaret Hospital in Hong Kong is a leading healthcare institution renowned for its commitment to advanced cancer care and innovative research. As a prominent clinical trial sponsor, the hospital focuses on developing and evaluating new therapeutic strategies to improve patient outcomes in oncology. With a multidisciplinary team of experts and state-of-the-art facilities, Princess Margaret Hospital actively engages in cutting-edge clinical trials, fostering collaboration with international research networks to contribute to the global fight against cancer. Its dedication to patient-centered care and scientific excellence positions it at the forefront of clinical research in the region.

Locations

Patients applied

0 patients applied

Trial Officials

Cheuk Yin Lo, MBBS

Principal Investigator

Princess Margaret Hospital, Canada

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported